Starting June 1, 2006, Colorado Medicaid engaged in a two-year project with Comprehensive NeuroScience (CNS) to provide prescribers information about the psychiatric medication utilization of their patients. This program is designed to help ensure that Colorado Medicaid clients receive the best care possible. This program will send educational alerts/letters to prescribers to help them know if the medication dosing is in line with FDA guidelines and, for children, research and consensus based guidelines. The messages are advisory and intended to be supportive. Prescribers are asked to review each case in the context of the guidelines and decide individually what is best for the patient. The program is also designed to notify prescribers about forgotten refills and alerts all involved prescribers if a patient obtains same class drugs from multiple prescribers. CNS is an independent company with experience in evidence-based and consensus-based standards for psychiatric medication prescribing.

The program ended June 30, 2008.  Results of the program were discussed at a final stakeholder meeting that was held September 30, 2008.  Questions about the program can be addressed to Kim Eggert at kimberly.eggert@state.co.us